Chronic myeloid leukemia, BCR/ABL-positive

Clinical trials for Chronic myeloid leukemia, BCR/ABL-positive explained in plain language.

Never miss a new study

Get alerted when new Chronic myeloid leukemia, BCR/ABL-positive trials appear

Sign up with your email to follow new studies for Chronic myeloid leukemia, BCR/ABL-positive, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

CML drug combo aims for Treatment-Free remission, but trial stalls

Disease control Stopped early

This phase 3 trial tested whether adding asciminib to the standard drug imatinib could help people with chronic myeloid leukemia (CML) achieve a deep remission and safely stop all medication. Only 8 patients were enrolled before the study was terminated early, making it too small…

Matched conditions: CHRONIC MYELOID LEUKEMIA, BCR/ABL-POSITIVE

Phase 3 • Sponsor: Sarit Assouline • Aim: Disease control

Last updated Jun 27, 2026 13:00 UTC

Chronic myeloid leukemia, BCR/ABL-positive

Get alerted when new Chronic myeloid leukemia, BCR/ABL-positive trials appear

CML drug combo aims for Treatment-Free remission, but trial stalls